Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis

Documenti analoghi

• Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
  di: Friedemann Schad, et al.
  Pubblicazione: (2022-01-01)
• Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.
  di: Friedemann Schad, et al.
  Pubblicazione: (2022-01-01)
• Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients.
  di: Anja Thronicke, et al.
  Pubblicazione: (2020-01-01)
• Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
  di: Anja Thronicke, et al.
  Pubblicazione: (2017-12-01)
• Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients
  di: Anja Thronicke, et al.
  Pubblicazione: (2018-09-01)